Loading...
Phosphodiesterase isoforms and cAMP compartments in the development of new therapies for obstructive pulmonary diseases
The second messenger molecule 3’5’-cyclic adenosine monophosphate (cAMP) imparts several beneficial effects in lung diseases such as asthma, chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). While cAMP is bronchodilatory in asthma and COPD, it also displays anti-f...
Saved in:
| Published in: | Curr Opin Pharmacol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7529846/ https://ncbi.nlm.nih.gov/pubmed/32622335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coph.2020.05.002 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|